1567 related articles for article (PubMed ID: 28530702)
41. Metformin Affects Gut Microbiome Composition and Function and Circulating Short-Chain Fatty Acids: A Randomized Trial.
Mueller NT; Differding MK; Zhang M; Maruthur NM; Juraschek SP; Miller ER; Appel LJ; Yeh HC
Diabetes Care; 2021 Jul; 44(7):1462-1471. PubMed ID: 34006565
[TBL] [Abstract][Full Text] [Related]
42. Spatial variation of the gut microbiome in response to long-term metformin treatment in high-fat diet-induced type 2 diabetes mouse model of both sexes.
Silamiķele L; Saksis R; Silamiķelis I; Kotoviča PP; Brīvība M; Kalniņa I; Kalniņa Z; Fridmanis D; Kloviņš J
Gut Microbes; 2023; 15(1):2188663. PubMed ID: 36927522
[TBL] [Abstract][Full Text] [Related]
43. Peanut skin extract ameliorates the symptoms of type 2 diabetes mellitus in mice by alleviating inflammation and maintaining gut microbiota homeostasis.
Xiang L; Wu Q; Osada H; Yoshida M; Pan W; Qi J
Aging (Albany NY); 2020 Jul; 12(14):13991-14018. PubMed ID: 32699185
[TBL] [Abstract][Full Text] [Related]
44. Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial.
Tong X; Xu J; Lian F; Yu X; Zhao Y; Xu L; Zhang M; Zhao X; Shen J; Wu S; Pang X; Tian J; Zhang C; Zhou Q; Wang L; Pang B; Chen F; Peng Z; Wang J; Zhen Z; Fang C; Li M; Chen L; Zhao L
mBio; 2018 May; 9(3):. PubMed ID: 29789365
[TBL] [Abstract][Full Text] [Related]
45. Metformin Strongly Affects Gut Microbiome Composition in High-Fat Diet-Induced Type 2 Diabetes Mouse Model of Both Sexes.
Silamiķele L; Silamiķelis I; Ustinova M; Kalniņa Z; Elbere I; Petrovska R; Kalniņa I; Kloviņš J
Front Endocrinol (Lausanne); 2021; 12():626359. PubMed ID: 33815284
[TBL] [Abstract][Full Text] [Related]
46. Pleiotropic effects of metformin: Shaping the microbiome to manage type 2 diabetes and postpone ageing.
Prattichizzo F; Giuliani A; Mensà E; Sabbatinelli J; De Nigris V; Rippo MR; La Sala L; Procopio AD; Olivieri F; Ceriello A
Ageing Res Rev; 2018 Dec; 48():87-98. PubMed ID: 30336272
[TBL] [Abstract][Full Text] [Related]
47. Metformin Alters mRNA Expression of
Petakh P; Kamyshna I; Oksenych V; Kamyshnyi O
Viruses; 2024 Feb; 16(2):. PubMed ID: 38400056
[TBL] [Abstract][Full Text] [Related]
48. Efficacy of metformin and fermentable fiber combination therapy in adolescents with severe obesity and insulin resistance: study protocol for a double-blind randomized controlled trial.
Deehan EC; Colin-Ramirez E; Triador L; Madsen KL; Prado CM; Field CJ; Ball GDC; Tan Q; Orsso C; Dinu I; Pakseresht M; Rubin D; Sharma AM; Tun H; Walter J; Newgard CB; Freemark M; Wine E; Haqq AM
Trials; 2021 Feb; 22(1):148. PubMed ID: 33596993
[TBL] [Abstract][Full Text] [Related]
49. Effects of vancomycin-induced gut microbiome alteration on the pharmacodynamics of metformin in healthy male subjects.
Kim E; Kim AH; Lee Y; Ji SC; Cho JY; Yu KS; Chung JY
Clin Transl Sci; 2021 Sep; 14(5):1955-1966. PubMed ID: 33982376
[TBL] [Abstract][Full Text] [Related]
50. Alteration of gut microbiota induced by DPP-4i treatment improves glucose homeostasis.
Liao X; Song L; Zeng B; Liu B; Qiu Y; Qu H; Zheng Y; Long M; Zhou H; Wang Y; Du Y; Xu J; Shen R; Tong Q; Cai L; Li X; Guo S; Yang G; Zhu Z; Pu X; Wei H; Zheng H
EBioMedicine; 2019 Jun; 44():665-674. PubMed ID: 30922964
[TBL] [Abstract][Full Text] [Related]
51. Involvement of glucagon-like peptide-1 in the glucose-lowering effect of metformin.
Bahne E; Hansen M; Brønden A; Sonne DP; Vilsbøll T; Knop FK
Diabetes Obes Metab; 2016 Oct; 18(10):955-61. PubMed ID: 27265206
[TBL] [Abstract][Full Text] [Related]
52. Gut microbiota compositions and metabolic functions in type 2 diabetes differ with glycemic durability to metformin monotherapy.
Hung WW; Peng P; Tsai YC; Jhou PS; Chang CC; Hsieh CC; Su YC; Dai CY; Hung WC
Diabetes Res Clin Pract; 2021 Apr; 174():108731. PubMed ID: 33676995
[TBL] [Abstract][Full Text] [Related]
53. Effects of Qijian mixture on type 2 diabetes assessed by metabonomics, gut microbiota and network pharmacology.
Gao K; Yang R; Zhang J; Wang Z; Jia C; Zhang F; Li S; Wang J; Murtaza G; Xie H; Zhao H; Wang W; Chen J
Pharmacol Res; 2018 Apr; 130():93-109. PubMed ID: 29391233
[TBL] [Abstract][Full Text] [Related]
54. Insulin Sensitivity-Enhancing Activity of Phlorizin Is Associated with Lipopolysaccharide Decrease and Gut Microbiota Changes in Obese and Type 2 Diabetes (db/db) Mice.
Mei X; Zhang X; Wang Z; Gao Z; Liu G; Hu H; Zou L; Li X
J Agric Food Chem; 2016 Oct; 64(40):7502-7511. PubMed ID: 27635781
[TBL] [Abstract][Full Text] [Related]
55. Increased circulating butyrate and ursodeoxycholate during probiotic intervention in humans with type 2 diabetes.
McMurdie PJ; Stoeva MK; Justice N; Nemchek M; Sieber CMK; Tyagi S; Gines J; Skennerton CT; Souza M; Kolterman O; Eid J
BMC Microbiol; 2022 Jan; 22(1):19. PubMed ID: 34996347
[TBL] [Abstract][Full Text] [Related]
56. Metformin exerts anti-obesity effect via gut microbiome modulation in prediabetics: A hypothesis.
Maniar K; Moideen A; Bhattacharyya R; Banerjee D
Med Hypotheses; 2017 Jul; 104():117-120. PubMed ID: 28673568
[TBL] [Abstract][Full Text] [Related]
57. Analyzing Type 2 Diabetes Associations with the Gut Microbiome in Individuals from Two Ethnic Backgrounds Living in the Same Geographic Area.
Balvers M; Deschasaux M; van den Born BJ; Zwinderman K; Nieuwdorp M; Levin E
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579166
[TBL] [Abstract][Full Text] [Related]
58. The gut microbiome and type 2 diabetes status in the Multiethnic Cohort.
Maskarinec G; Raquinio P; Kristal BS; Setiawan VW; Wilkens LR; Franke AA; Lim U; Le Marchand L; Randolph TW; Lampe JW; Hullar MAJ
PLoS One; 2021; 16(6):e0250855. PubMed ID: 34161346
[TBL] [Abstract][Full Text] [Related]
59. The combination of linagliptin, metformin and lifestyle modification to prevent type 2 diabetes (PRELLIM). A randomized clinical trial.
Guardado-Mendoza R; Salazar-López SS; Álvarez-Canales M; Farfán-Vázquez D; Martínez-López YE; Jiménez-Ceja LM; Suárez-Pérez EL; Angulo-Romero F; Evia-Viscarra ML; Montes de Oca-Loyola ML; Durán-Pérez EG; Folli F; Aguilar-García A
Metabolism; 2020 Mar; 104():154054. PubMed ID: 31887309
[TBL] [Abstract][Full Text] [Related]
60. Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents.
Almugadam BS; Liu Y; Chen SM; Wang CH; Shao CY; Ren BW; Tang L
J Diabetes Res; 2020; 2020():7253978. PubMed ID: 33062716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
